Ferroptosis contributes to immunosuppression
- PMID: 39560919
- DOI: 10.1007/s11684-024-1080-8
Ferroptosis contributes to immunosuppression
Abstract
As a novel form of cell death, ferroptosis is mainly regulated by the accumulation of soluble iron ions in the cytoplasm and the production of lipid peroxides and is closely associated with several diseases, including acute kidney injury, ischemic reperfusion injury, neurodegenerative diseases, and cancer. The term "immunosuppression" refers to various factors that can directly harm immune cells' structure and function and affect the synthesis, release, and biological activity of immune molecules, leading to the insufficient response of the immune system to antigen production, failure to successfully resist the invasion of foreign pathogens, and even organ damage and metabolic disorders. An immunosuppressive phase commonly occurs in the progression of many ferroptosis-related diseases, and ferroptosis can directly inhibit immune cell function. However, the relationship between ferroptosis and immunosuppression has not yet been published due to their complicated interactions in various diseases. Therefore, this review deeply discusses the contribution of ferroptosis to immunosuppression in specific cases. In addition to offering new therapeutic targets for ferroptosis-related diseases, the findings will help clarify the issues on how ferroptosis contributes to immunosuppression.
Keywords: ferroptosis; immune cells; immunosuppression.
© 2024. Higher Education Press.
Conflict of interest statement
Compliance with ethics guidelines. Conflict of interests Nina He, Dun Yuan, Minjie Luo, Qing Xu, Zhongchi Wen, Ziqin Wang, Jie Zhao and Ying Liu declare that they have no conflict of interest. This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.
Similar articles
-
Ferroptosis in immunostimulation and immunosuppression.Immunol Rev. 2024 Jan;321(1):199-210. doi: 10.1111/imr.13235. Epub 2023 Jul 9. Immunol Rev. 2024. PMID: 37424139 Review.
-
Ferroptosis: a novel perspective on tumor immunotherapy.Front Immunol. 2025 Apr 7;16:1524711. doi: 10.3389/fimmu.2025.1524711. eCollection 2025. Front Immunol. 2025. PMID: 40260246 Free PMC article. Review.
-
Ferroptosis in heart failure.J Mol Cell Cardiol. 2022 Dec;173:141-153. doi: 10.1016/j.yjmcc.2022.10.004. Epub 2022 Oct 20. J Mol Cell Cardiol. 2022. PMID: 36273661 Free PMC article. Review.
-
Ferroptosis Is Regulated by Mitochondria in Neurodegenerative Diseases.Neurodegener Dis. 2020;20(1):20-34. doi: 10.1159/000510083. Epub 2020 Aug 19. Neurodegener Dis. 2020. PMID: 32814328 Review.
-
The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury.Life Sci. 2024 Mar 1;340:122439. doi: 10.1016/j.lfs.2024.122439. Epub 2024 Jan 24. Life Sci. 2024. PMID: 38278348 Review.
Cited by
-
Lipotoxicity, lipid peroxidation and ferroptosis: a dilemma in cancer therapy.Cell Biol Toxicol. 2025 Apr 26;41(1):75. doi: 10.1007/s10565-025-10025-7. Cell Biol Toxicol. 2025. PMID: 40285867 Free PMC article. Review.
References
-
- Stockwell BR, Angeli JPF, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE, Noel K, Jiang XJ, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang DL, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 2017; 171(2): 273–285 - PubMed - PMC - DOI
-
- Nakamura E, Sato M, Yang HL, Miyagawa F, Harasaki M, Tomita K, Matsuoka S, Noma A, Iwai K, Minato N. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 1999; 274(5): 3009–3016 - PubMed - DOI
-
- Koppula P, Zhang YL, Zhuang L, Gan BY. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun 2018; 38(1): 12 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials